- Home
- ORGO vs ITIC Comparison
ORGO vs ITIC Comparison
Compare ORGO & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ITIC
- Stock Information
- Founded
- ORGO 1985
- ITIC 1972
- Country
- ORGO United States
- ITIC United States
- Employees
- ORGO N/A
- ITIC N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ITIC Specialty Insurers
- Sector
- ORGO Health Care
- ITIC Finance
- Exchange
- ORGO Nasdaq
- ITIC Nasdaq
- Market Cap
- ORGO 465.6M
- ITIC 440.1M
- IPO Year
- ORGO N/A
- ITIC N/A
- Fundamental
- Price
- ORGO $4.89
- ITIC $246.67
- Analyst Decision
- ORGO Buy
- ITIC
- Analyst Count
- ORGO 2
- ITIC 0
- Target Price
- ORGO $7.50
- ITIC N/A
- AVG Volume (30 Days)
- ORGO 642.5K
- ITIC 36.6K
- Earning Date
- ORGO 08-07-2025
- ITIC 08-06-2025
- Dividend Yield
- ORGO N/A
- ITIC 6.42%
- EPS Growth
- ORGO N/A
- ITIC 25.49
- EPS
- ORGO N/A
- ITIC 17.49
- Revenue
- ORGO $429,531,000.00
- ITIC $269,460,000.00
- Revenue This Year
- ORGO $2.57
- ITIC N/A
- Revenue Next Year
- ORGO $9.80
- ITIC N/A
- P/E Ratio
- ORGO N/A
- ITIC $13.60
- Revenue Growth
- ORGO N/A
- ITIC 15.27
- 52 Week Low
- ORGO $2.46
- ITIC $190.20
- 52 Week High
- ORGO $6.71
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- ORGO 59.08
- ITIC 67.92
- Support Level
- ORGO $4.41
- ITIC $230.57
- Resistance Level
- ORGO $4.90
- ITIC $241.70
- Average True Range (ATR)
- ORGO 0.30
- ITIC 7.79
- MACD
- ORGO -0.03
- ITIC 1.12
- Stochastic Oscillator
- ORGO 92.58
- ITIC 94.25
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.